AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23474436 — intervention group
Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 53
Study 21457567 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer coaching (n = 200)
Number of subjects: 400
Study 21457567 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n = 200)
Number of subjects: 400
Study 19041437 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel‐releasing intrauterine system (LNG‐IUS)
Number of subjects: 92
Study 19041437 — intervention group
Group type: COMPARATOR
Intervention: Ortho Gynae T380 intrauterine copper device (IUD)
Number of subjects: 92
Study 16412866 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 30, 100, or 325 mg/day
Number of subjects: 114
Study 16412866 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved metabolic control
Number of subjects: 114
Study 16412866 — intervention group
Group type: COMPARATOR
Intervention: Control patients (healthy volunteers)
Number of subjects: 114
Study 15622577 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial bowel sphincter (Acticon Neosphincter)
Number of subjects: 14
Study 15622577 — intervention group
Group type: COMPARATOR
Intervention: Supportive care (Control)
Number of subjects: 14
Study 11484571 — intervention group
Group type: EXPERIMENTAL
Intervention: Aluminous oxide pink stone surface treatment
Number of subjects: 20
Study 11484571 — intervention group
Group type: EXPERIMENTAL
Intervention: 50‐micron aluminum oxide sandblasting surface treatment
Number of subjects: 20
Study 11484571 — intervention group
Group type: EXPERIMENTAL
Intervention: Brown rubber point surface treatment
Number of subjects: 20
Study 11484571 — intervention group
Group type: EXPERIMENTAL
Intervention: Gray silicone wheel followed by pink silicone wheel surface treatment
Number of subjects: 20
Study 9783532 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 20
Study 10161100 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% dietary fat intake
Number of subjects: 35
Study 10161100 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% dietary fat intake
Number of subjects: 35
Study 10161100 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% dietary fat intake
Number of subjects: 35
Study 10161100 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% dietary fat intake
Number of subjects: 35
Study 2849376 — intervention group
Group type: COMPARATOR
Intervention: Intranasally administered rhinovirus receptor murine monoclonal antibody (RRMA) 135 micrograms/subject in 9 applications, -17 to +48 h
Number of subjects: 28
Study 2849376 — intervention group
Group type: COMPARATOR
Intervention: Intranasally administered rhinovirus receptor murine monoclonal antibody (RRMA) 1 mg/subject in 10 applications, -3 to +36 h
Number of subjects: 28
Study 30917201 — intervention group
Group type: EXPERIMENTAL
Intervention: SystemCHANGE™ intervention
Number of subjects: 0
Study 30917201 — intervention group
Group type: COMPARATOR
Intervention: Attention-control group
Number of subjects: 0
Study 27655918 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate multivessel PCI
Number of subjects: 600
Study 27655918 — intervention group
Group type: COMPARATOR
Intervention: Culprit lesion PCI
Number of subjects: 600
Study 25411362 — intervention group
Group type: EXPERIMENTAL
Intervention: Postexercise protein-carbohydrate supplementation
Number of subjects: 17
Study 25411362 — intervention group
Group type: COMPARATOR
Intervention: No supplementation (control)
Number of subjects: 17
Study 23537225 — intervention group
Group type: EXPERIMENTAL
Intervention: Grain bar preload
Number of subjects: 59
Study 21722270 — intervention group
Group type: EXPERIMENTAL
Intervention: Back of the Net (BTN)
Number of subjects: 104
Study 21722270 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Exercise (IE)
Number of subjects: 104
Study 21722270 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 104
Study 18996012 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior/Posterior weight shifting (WS) practice (n=20)
Number of subjects: 56
Study 18996012 — intervention group
Group type: EXPERIMENTAL
Intervention: Medio/Lateral weight shifting (WS) practice (n=20)
Number of subjects: 56
Study 18996012 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=16)
Number of subjects: 56
Study 16339086 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 40
Study 16339086 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 40
Study 15004731 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol 25 mg b.i.d. for 6 days
Number of subjects: 17
Study 15004731 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg b.i.d. for 6 days
Number of subjects: 17
Study 15004731 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 days
Number of subjects: 17
Study 10718795 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 40 microg/kg
Number of subjects: 120
Study 10718795 — intervention group
Group type: COMPARATOR
Intervention: Droperidol 20 microg/kg
Number of subjects: 120
Study 10718795 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide 0.2 mg/kg
Number of subjects: 120
Study 9376523 — intervention group
Group type: EXPERIMENTAL
Intervention: Explicit conditions for surface structure learning
Number of subjects: 0
Study 9376523 — intervention group
Group type: EXPERIMENTAL
Intervention: Explicit conditions for abstract structure learning
Number of subjects: 0
Study 9376523 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit conditions
Number of subjects: 0
Study 1546725 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 785
Study 1546725 — intervention group
Group type: EXPERIMENTAL
Intervention: Mealtime antacids (80 mmol/day)
Number of subjects: 785
Study 1546725 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimipramine 25 mg
Number of subjects: 785
Study 1546725 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirenzepine 50 mg
Number of subjects: 785
Study 1546725 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 200 mg
Number of subjects: 785
Study 1546725 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg
Number of subjects: 785
Study 1546725 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg
Number of subjects: 785
Study 1546725 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate 1 g twice a day
Number of subjects: 785
Study 1546725 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg, antacids, ranitidine 150 mg, and sucralfate
Number of subjects: 785
Study 1546725 — intervention group
Group type: EXPERIMENTAL
Intervention: Antacids
Number of subjects: 785
Study 3889723 — intervention group
Group type: EXPERIMENTAL
Intervention: Buflomedil
Number of subjects: 0
Study 3889723 — intervention group
Group type: COMPARATOR
Intervention: Nicergolin
Number of subjects: 0
Study 31227385 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral weight control trial
Number of subjects: 181
Study 31227385 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity
Number of subjects: 181
Study 31227385 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity reduction
Number of subjects: 181
Study 30126536 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer Network Counseling-txt (PNC-txt)
Number of subjects: 30
Study 25809315 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise program
Number of subjects: 140
Study 25809315 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopic acromioplasty followed by a similar exercise program
Number of subjects: 140
Study 23642733 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate continuous exercise
Number of subjects: 30
Study 23642733 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense intermittent exercise
Number of subjects: 30
Study 23642733 — intervention group
Group type: COMPARATOR
Intervention: No exercise (control)
Number of subjects: 30
Study 21124256 — intervention group
Group type: EXPERIMENTAL
Intervention: PPV with densiron (n = 15)
Number of subjects: 30
Study 21124256 — intervention group
Group type: COMPARATOR
Intervention: PPV with silicone oil (n = 15)
Number of subjects: 30
Study 19954711 — intervention group
Group type: EXPERIMENTAL
Intervention: Bemiparin 3500 IU
Number of subjects: 12
Study 19954711 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin 4000 IU
Number of subjects: 12
Study 17577112 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg hydrotalcite
Number of subjects: 562
Study 17577112 — intervention group
Group type: COMPARATOR
Intervention: 10 mg famotidine
Number of subjects: 562
Study 17577112 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 562
Study 15247745 — intervention group
Group type: EXPERIMENTAL
Intervention: Holmium laser resection of the prostate (HoLRP)
Number of subjects: 120
Study 15247745 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 120
Study 12364302 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate DAFNE training
Number of subjects: 169
Study 12364302 — intervention group
Group type: COMPARATOR
Intervention: Delayed DAFNE training
Number of subjects: 169
Study 9691103 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 9 mg once daily
Number of subjects: 182
Study 9691103 — intervention group
Group type: COMPARATOR
Intervention: Mesalamine 2 g twice daily
Number of subjects: 182
Study 9691103 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 182
Study 9691103 — intervention group
Group type: COMPARATOR
Intervention: Mesalamine
Number of subjects: 182
Study 10658944 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate (ISMN)
Number of subjects: 10
Study 1991926 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI 204,219
Number of subjects: 18
Study 1991926 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 6600418 — intervention group
Group type: EXPERIMENTAL
Intervention: Bypass surgery
Number of subjects: 100
Study 6600418 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 100
Study 31241784 — intervention group
Group type: EXPERIMENTAL
Intervention: Autogenous tooth roots (TR)
Number of subjects: 23
Study 31241784 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortical autogenous bone blocks (AB)
Number of subjects: 23
Study 30213798 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile application added to usual care
Number of subjects: 60
Study 30213798 — intervention group
Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 60
Study 30213798 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 27055211 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifitegrast ophthalmic solution 5.0%
Number of subjects: 331
Study 27055211 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 331
Study 24929350 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegnivacogin 1 mg/kg with 25% anivamersen reversal
Number of subjects: 640
Study 24929350 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegnivacogin 1 mg/kg with 50% anivamersen reversal
Number of subjects: 640
Study 24929350 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegnivacogin 1 mg/kg with 75% anivamersen reversal
Number of subjects: 640
Study 24929350 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegnivacogin 1 mg/kg with 100% anivamersen reversal
Number of subjects: 640
Study 24929350 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 640
Study 24929350 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegnivacogin
Number of subjects: 640
Study 24929350 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 640
Study 23336487 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic virtual reality simulator
Number of subjects: 26
Study 23336487 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic box trainer
Number of subjects: 26
Study 20559104 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiopronin (3 g/d)
Number of subjects: 9
Study 20559104 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiopronin (1 g/d to 3 g/d)
Number of subjects: 9
Study 18398627 — intervention group
Group type: EXPERIMENTAL
Intervention: Restorative dental care (ART)
Number of subjects: 380
Study 18398627 — intervention group
Group type: COMPARATOR
Intervention: Only extractions
Number of subjects: 380
Study 18398627 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 380
Study 18398627 — intervention group
Group type: COMPARATOR
Intervention: Full dental treatment
Number of subjects: 380
Study 15673873 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulation patterns (300‐500 V; 100‐1000 Hz; 1‐5 stimuli) at different propofol target plasma concentrations (PTPCs) (2, 4, and 6 microg/mL)
Number of subjects: 12
Study 15673873 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol target plasma concentrations (PTPCs) (2, 4, and 6 microg/mL)
Number of subjects: 12
Study 12058095 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen 75 mg
Number of subjects: 235
Study 12058095 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen 150 mg
Number of subjects: 235
Study 12058095 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolmitriptan 2.5 mg
Number of subjects: 235
Study 12058095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 235
Study 9857785 — intervention group
Group type: EXPERIMENTAL
Intervention: More frequent contact with family and friends among respondents with GAF scores in the lowest 20%
Number of subjects: 331
Study 9857785 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent social contact among better functioning respondents
Number of subjects: 331
Study 8296845 — intervention group
Group type: EXPERIMENTAL
Intervention: Preterm birth prevention education plus increased clinic visits and selected prophylactic interventions
Number of subjects: 1774
Study 8296845 — intervention group
Group type: COMPARATOR
Intervention: Standard county care
Number of subjects: 1774
Study 2742247 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted inspiratory muscle training
Number of subjects: 19
Study 2742247 — intervention group
Group type: COMPARATOR
Intervention: Control group (constant, nominal level of resistance)
Number of subjects: 19
Study 1096930 — intervention group
Group type: EXPERIMENTAL
Intervention: 1200 calorie diet
Number of subjects: 51
Study 1096930 — intervention group
Group type: EXPERIMENTAL
Intervention: cyclopenthiazide with potassium
Number of subjects: 51
Study 1096930 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 51
Study 1096930 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 51
Study 30961672 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 active ABCR sessions twice a week
Number of subjects: 0
Study 30961672 — intervention group
Group type: COMPARATOR
Intervention: Control group sessions twice a week
Number of subjects: 0
Study 28975241 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 3876
Study 28975241 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3876
Study 25694300 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin lispro protamine
Number of subjects: 49
Study 25694300 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 49
Study 25694300 — intervention group
Group type: COMPARATOR
Intervention: Insulin detemir
Number of subjects: 49
Study 23404154 — intervention group
Group type: EXPERIMENTAL
Intervention: Left capnothorax first (Group L)
Number of subjects: 40
Study 23404154 — intervention group
Group type: COMPARATOR
Intervention: Right capnothorax first (Group R)
Number of subjects: 40
Study 20940648 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training in water-based exercises (RWE)
Number of subjects: 27
Study 20940648 — intervention group
Group type: COMPARATOR
Intervention: Water-based exercises without resistance control (WE)
Number of subjects: 27
Study 20940648 — intervention group
Group type: COMPARATOR
Intervention: Non-training control (CON)
Number of subjects: 27
Study 18847131 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological treatment with antidepressants (specifics not provided)
Number of subjects: 0
Study 16649858 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecure attachment
Number of subjects: 124
Study 16649858 — intervention group
Group type: COMPARATOR
Intervention: Secure attachment
Number of subjects: 124
Study 16649858 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecurely attached partners
Number of subjects: 124
Study 16649858 — intervention group
Group type: COMPARATOR
Intervention: Securely attached partners
Number of subjects: 124
Study 12929879 — intervention group
Group type: COMPARATOR
Intervention: Calcium intake in children with rickets (285 +/- 113 mg/day)
Number of subjects: 40
Study 12929879 — intervention group
Group type: COMPARATOR
Intervention: Calcium intake in adolescents with rickets (305 +/- 196 mg/day)
Number of subjects: 40
Study 12929879 — intervention group
Group type: COMPARATOR
Intervention: Sun exposure in children with rickets (55 +/- 28 min x m2/day)
Number of subjects: 40
Study 12929879 — intervention group
Group type: COMPARATOR
Intervention: 25 hydroxyvitamin D in children with rickets (49 +/- 38 nmol/l)
Number of subjects: 40
Study 12929879 — intervention group
Group type: COMPARATOR
Intervention: Sun exposure in adolescents with rickets (16 +/- 15 min x m2/day)
Number of subjects: 40
Study 12929879 — intervention group
Group type: COMPARATOR
Intervention: Serum 25 hydroxyvitamin D in adolescents with rickets (12.6 +/- 7.1 nmol/l)
Number of subjects: 40
Study 12929879 — intervention group
Group type: EXPERIMENTAL
Intervention: Odds ratio for developing rickets with daily calcium intake below 300 mg
Number of subjects: 40
Study 12929879 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium treatment (1 g daily) in children
Number of subjects: 40
Study 12929879 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium treatment (1 g daily) in adolescents
Number of subjects: 40
Study 10666663 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 0
Study 10666663 — intervention group
Group type: COMPARATOR
Intervention: Implantable cardioverter-defibrillators (ICD)
Number of subjects: 0
Study 10666663 — intervention group
Group type: EXPERIMENTAL
Intervention: Empiric amiodarone
Number of subjects: 0
Study 10666663 — intervention group
Group type: COMPARATOR
Intervention: ICD therapy
Number of subjects: 0
Study 9272978 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 200
Study 9272978 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 1357124 — intervention group
Group type: EXPERIMENTAL
Intervention: sCD4 (100, 300, and 1000 micrograms/kg per day)
Number of subjects: 11
Study 1357124 — intervention group
Group type: EXPERIMENTAL
Intervention: sCD4 plus dideoxyinosine (90 mg/m2 every 8 hours)
Number of subjects: 11
Study 1357124 — intervention group
Group type: EXPERIMENTAL
Intervention: sCD4 alone
Number of subjects: 11
Study 1357124 — intervention group
Group type: EXPERIMENTAL
Intervention: sCD4 plus dideoxyinosine combination therapy
Number of subjects: 11
Study 2409543 — intervention group
Group type: EXPERIMENTAL
Intervention: Flecainide acetate (200 mg twice daily)
Number of subjects: 14
Study 29063186 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice bran (n=35)
Number of subjects: 105
Study 29063186 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice husk powder (n=35)
Number of subjects: 105
Study 29063186 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=35)
Number of subjects: 105
Study 27852545 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic preparation containing Lactobacillus casei, L. plantarum, L. rhamnosus, Bifidobacterium lactis and prebiotics
Number of subjects: 0
Study 27852545 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc suspension (15 mg/day for 5 days)
Number of subjects: 0
Study 27852545 — intervention group
Group type: COMPARATOR
Intervention: Control group (ORS and/or intravenous therapy)
Number of subjects: 0
Study 27852545 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc group
Number of subjects: 0
Study 27852545 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic group
Number of subjects: 0
Study 24811326 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal Calorie Monitor (PCM) in thermoneutral conditions
Number of subjects: 34
Study 24811326 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal Calorie Monitor (PCM) in cool conditions
Number of subjects: 34
Study 24811326 — intervention group
Group type: COMPARATOR
Intervention: Indirect calorimetry (IC) in thermoneutral conditions
Number of subjects: 34
Study 24811326 — intervention group
Group type: COMPARATOR
Intervention: Indirect calorimetry (IC) in cool conditions
Number of subjects: 34
Study 23242727 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone ointment
Number of subjects: 83
Study 23242727 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone + mupirocin ointment
Number of subjects: 83
Study 23242727 — intervention group
Group type: COMPARATOR
Intervention: Emollient ointment
Number of subjects: 83
Study 20213468 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic training (IT) at 80 rpm
Number of subjects: 18
Study 20213468 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight training (WT)
Number of subjects: 18
Study 20213468 — intervention group
Group type: COMPARATOR
Intervention: Both groups (WT and IT)
Number of subjects: 18
Study 18798830 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproic acid (VPA) intravenous (i.v.)
Number of subjects: 74
Study 18798830 — intervention group
Group type: COMPARATOR
Intervention: Phenytoin (PHT) intravenous (i.v.)
Number of subjects: 74
Study 15849424 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple polyphenol (Ap) 500 mg once daily for 12 weeks
Number of subjects: 0
Study 15849424 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11831005 — intervention group
Group type: EXPERIMENTAL
Intervention: ecabet sodium
Number of subjects: 21
Study 11831005 — intervention group
Group type: EXPERIMENTAL
Intervention: rebamipide
Number of subjects: 21
Study 10428581 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 25
Study 7745785 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia plus epidural anesthesia (bupivacaine 0.25% with 200,000 epinephrine, 0.75 ml.kg‐1)
Number of subjects: 21